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Abstract 
 
This pilot study examined the feasibility of applying Contingency Management (CM), 
where the woman receives financial compensation for abstinence from smoking. Eleven 
subjects were recruited from Marshall’s OB clinic for the program. CO levels were 
measured daily using online video recording. Quit rates were determined at the end of 
pregnancy. Birth outcomes were measured at delivery. 21 pregnant smokers from 
Marshall’s OB clinic were used as the control group. The results demonstrated a trend 
toward improved rates of smoking abstinence in CM participants as compared with the 
control group. Our study also showed a trend towards improved birth outcomes in the 
CM group. However, the results were not statistically significant, and we believe a larger 
study in our population is warranted. 
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Introduction 
 
We have evidence of the harmful effects on the fetus of maternal smoking during 
pregnancy from as early as 1957, when maternal smoking was found to be associated 
with prematurity.1 Although smoking during pregnancy has decreased in recent decades, 
it is still considered the top preventable cause of poor birth outcomes in the United 
States.2,3 Smokers have an increased risk of ectopic pregnancy, spontaneous abortion, 
placental abruption, placenta previa, preterm birth, low birthweight (LBW), stillbirth, and 
sudden infant death syndrome (SIDS). After birth, the children of smokers are at 
increased risk for behavioral problems, attention deficit disorder, hyperactivity, learning 
disability, obesity, elevated blood pressure, diabetes, and an increased risk of becoming 
smokers themselves.3 Additionally, the newborn is at increased risk for cognitive 
problems, ear infections, bronchitis, pneumonia, asthma, and SIDS if exposed to 
secondhand smoke postpartum.4  
 
Although the rate of maternal tobacco use during pregnancy has dropped, certain 
populations such as Appalachians still have high rates of maternal tobacco use during 
pregnancy and associated high rates of poor birth outcomes. For example, in a study of 
more than 4,100 women surveyed in Appalachia, 25% were self-reported as smokers 
compared to the national rate of 12%.5 Additionally, babies born to rural women were on 
average 700 grams lighter and were born more than three weeks earlier. Unfortunately, 
rural women are less likely to use prenatal care; this is due to many factors, one of which 
is increased travel time to medical provider.5 
 
Contingency Management (CM), a program where the woman receives financial 
compensation as a reward for abstaining from smoking, has proven particularly effective 
in reducing smoking during pregnancy with up to 40% of participants achieving 
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abstinence by late pregnancy.2 The web-based version of this program is ideal in the rural 
population because it lessens the travel burden and provides frequent verification and 
reinforcement, two essential components for smoking abstinence that promote rapid 
change in behavior.6  
 
The primary aim of the study was to determine the benefit of CM on maternal smoking 
abstinence compared to pregnant smokers not enrolled in this program. Based on what we 
know about pregnant smokers, we hypothesize that the group receiving CM will achieve 
higher abstinence rates at delivery than pregnant smokers not enrolled in CM. 
Furthermore, this study assessed secondary outcomes such as birth weight, gestational 
age at birth, and NICU/NTU admissions.  
 
Methods 
 
In this pilot study, we recruited eleven pregnant smokers from the Marshall Health 
Obstetrics Clinic, located in Huntington West Virginia, a state entirely located in 
Appalachia. Participants were between the ages of 18 and 35 in their first 15 weeks, did 
not use recreational drugs aside from marijuana and had no history of diabetes. Marshall 
University IRB approved this study. 
 
Smoking status was defined as smoking at least two cigarettes per day and was confirmed 
via urine cotinine (>200ng/mL) or exhaled CO values (>10 parts per million (ppm)) at 
initial clinic visit. Recreational drug use was assessed using a urine test. Gestational age 
was determined using the date of last menstrual period (15 weeks or less) if ultrasound 
was not available.  
 
Marshall’s OB clinic was the source of the control group as it is the clinic from which the 
members of the CM group were recruited.  We reviewed the charts of all 210 labor and 
delivery patients seen during the same time frame as the CM group. Of those charts, 21 
patients met the screening criteria for the control group. Patients included were women 
aged 18-35 in their first 15 weeks who were self-reported smokers, denied recreational 
drug use aside from marijuana, had no history of diabetes, and would deliver in 
approximately the same time frame as the women in the active study group. Patients were 
excluded for incarceration, loss to follow up, and abortion. 
 
Using a provided computer with internet access, subjects participated in a contingency 
management (CM) program wherein they received financial compensation for reductions 
in cigarette use. Participants were required to videotape themselves twice daily giving a 
breath sample to determine breath CO using a provided monitor and to submit this 
videotape electronically to the investigators for review. Participants uploaded videos to 
the Motiv8 system using unique logins and passwords. Video submissions took 1-2 
minutes to record and had an 8-hour inter-sample interval. To leave a CO sample, 
participants showed the CO meter to the web camera, initiated the CO countdown screen, 
and held their breath for 15 seconds. They then exhaled into the meter, and displayed the 
meter to the camera. Patients received monetary compensation based on the contingency 
management protocol listed in Figure 1.  
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Figure 1. Contingency management timeline 
 
 
During phase 1 of the CM program, which lasted 7 days, women received $6 per day for 
providing two CO recordings on time regardless of CO value. These CO values were 
used to determine daily target values for the next phase, with a required reading below 5 
ppm as the final target value. Phase 2, which lasted 4 days, required participants to 
provide two CO breath samples per day, and participants were provided $3 for each 
breath sample with CO values below these predetermined target values. During phase 3, 
participants were provided $3 for each CO breath sample below 5 ppm. Additionally, 
rewards were escalated by $0.25 for each consecutive breath sample below 5 ppm during 
this time. If a CO value was 5 ppm or more during this time, the reward amount was reset 
to $3 for the next CO value below 5 ppm. Phase 3 lasted 21 days. Phase 4 provided $6 
per day for participants who provided two CO breath samples. Phase 4 lasted 5 days. 
Phase 5 provided $6 per day for providing both CO breath samples on time, regardless of 
CO value. Phase 5 lasted 5 days. 
 
The outcome data at birth including gestational-age at birth, birth weight, APGAR scores, 
and maternal smoking status were collected from the medical record. In addition, infant 
ICU visits in the first six months were documented. At monthly prenatal visits and the 6 
week postpartum follow-up visit, urine cotinine, exhaled CO, smoking rate over the 
previous two weeks, ratings of nicotine withdrawal, and smoking urges were assessed in 
the CM group. Patients were compensated 10 dollars for each visit. 
 
Our results were analyzed using Microsoft Excel. T-tests were calculated using 
Vassarstats.net on the “t-test for independent samples” section. Categorical data was 
analyzed using Fisher’s exact. 
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Results 
 
The average age of our pregnant smokers was 26 in the CM group and 25 in the control 
group.  T-test (0.69) showed no statistically significant difference in these values. There 
were 10 patients that self-identified as “white” and one participant that identified as 
“other” in the CM group. Racial data was not collected in the control group.  
 
Table 1. Participant Substance Use 
Substance 
CM %(n) 
(n=11) 
Control %(n) 
(n=21) 
P Value 
marijuana 9 [1] 10 [2] NS 
buprenorphine/naloxone 18 [2] 25 [5] NS 
methadone 9 [1] 10 [2] NS 
opiates 0 [0] 5 [1] NS 
oxycodone 0 [0] 5 [1] NS 
 
Table 1 shows participant and control substance use from urine dipsticks of samples at 
delivery. Both groups had marijuana use and buprenorphine or methadone use; however, 
only the control group had a participant positive for opiates and oxycodone. Fisher exact 
performed to attain p-value. 
 
* Urine drug screen was not performed in one patient in the control group and was 
excluded from results in this section. 
 
Table 2. CM Participant Outcomes 
 
Table 2 shows the results for the CM group. Three of the 11 patients withdrew from the 
study, but smoking status at delivery was retrieved from their medical records. Only 2 
participants submitted all of the requested CO readings. Four of the 5 patients with over 
80% compliance with the program were able to quit smoking. 
 
 
Enrollment 
Status 
Participation (Percent of 
required CO recordings 
submitted) 
Compensation 
(In Dollars) 
Quit 
MUOB1 Withdrew 6 22.00 Yes 
MUOB2 Withdrew 17 49.00 No 
MUOB3 Completed 86 234.50 Yes 
MUOB4 Completed 32 146.50 No 
MUOB5 Completed 81 126.75 No 
MUOB6 Completed 49 132.00 No 
MUOB7 Completed 100 259.75 Yes 
MUOB8 Completed 100 418.50 Yes 
MUOB9 Completed 22 49.00 No 
MUOB10 Completed 98 237.75 Yes 
MUOB11 Withdrew 11 22.00 No 
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Table 3. Maternal Cessation Rates and Birth Outcomes 
 
Table 3 shows birth outcomes. There was a trend towards higher average birth weight 
and average gestational age, and fewer NICU visits in the CM group compared to 
controls as shown in table 3. Also, 45% of the CM group was abstinent at delivery 
compared to 19% of controls. 
 
Figure 2: CM adherence among those who completed program 
 
Figure 2 shows program adherence rates for quit vs smoking at delivery among those 
who completed CM program. Adherence was greater in those who were able to quit 
smoking compared to those who did not quit (p=0.02). Overall adherence was 55%. 
Among those who completed the program, adherence was 71%. 
 
Discussion: 
 
Smoking during pregnancy is considered the top preventable cause of poor birth 
outcomes in the United States. However, smoking cessation resources are often difficult 
for the rural pregnant smoker to access due to economic and geographic obstacles. 
Previous studies have examined the feasibility of web-based CM in rural pregnant 
smokers, with positive results. In this pilot study in our Appalachian population, we 
showed a trend towards benefit of a home-based contingency management program for 
pregnant smokers on improving maternal smoking abstinence and birth outcomes as 
Birth Characteristics CM group 
(n=11) 
Control 
(n=21) 
P Value 
Maternal abstinence rate at delivery %(n) 45 (5) 19 (4) 0.21 
Average birth weight (g) 3466 3166 0.10 
Average gestational age  (weeks) 39.2 38.9 0.63 
Average number of ICU visits 0.19 0.57 0.13 
Average APGAR 8.72 8.1 0.22 
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compared to pregnant smokers not enrolled in this program. The benefit of smoking 
cessation was statistically significant in those who most adhered to the program. 
 
Our population had high rates of buprenorphine/methadone use and opiate drug abuse as 
demonstrated by urine drug testing at delivery in both the control and CM groups. This 
altered the birth outcome data as neonatal abstinence syndrome (NAS) mandates a 
NICU/NTU visit. In all cases, the reason listed in the medical records for NICU/NTU 
visits was for NAS. In addition, NAS and maternal tobacco use are both associated with 
low-birth weight (LBW). Only one infant in the study was classified as LBW (<2500g) 
and this was in the control group.  Still, it is difficult to draw conclusions about the 
contributing factors to this outcome given the small scale of the study (n=33). In a 
previous study, cigarette smoking in mothers taking opiate agonists was associated with 
longer NICU stays and increased morphine requirements to treat NAS.7 In our study, it is 
difficult to determine whether complications from fetal exposure to maternal tobacco use 
may have led to additional NICU/NTU admissions since our study was not designed to 
detect this difference. Treatment for NAS may last as long as a month in some cases, 
possibly preventing detection of additional ICU visits due to complications from maternal 
tobacco smoking. 
 
Investigators struggled with recruitment and retention of participants. The most 
commonly cited reasons for withdrawal from the study were stress and inability to 
commit time required to participate. Adherence to the CM program was lower in our 
program (55%) when compared to other programs which may be a reflection of our high 
risk population. For example, previous studies have shown a 65% adherence in adult 
rural smokers in CM programs with similar CO monitoring requirements.8 Among those 
who completed the program, we observed higher quit rates in those with greater 
adherence, which may indicate the importance of adherence in successful abstinence. 
Some studies that had more intensive CO monitoring requirements showed a lower (46%) 
adherence indicating more intensive monitoring could be a barrier to success.8 No 
instances of withdrawal from the program were attributed to inaccessibility or lack of 
needed resources (internet access, electricity, equipment, etc.), which is similar to other 
programs. However, our use of a laptop computer may not have been convenient for the 
patient, especially if they were away from home. Future research could test a contingency 
management app that could be used on a smart phone to see if this increases compliance 
with the program. 
 
One goal of our pilot study was to determine the benefit of CM in our population. We 
believe we have achieved this goal and a larger study in our population is warranted. 
Overall, we showed a trend towards improved rates of smoking abstinence during 
pregnancy in the CM group (0.45) as compared to routine care (0.19). However the scale 
of this pilot study was small, and there was not enough power to demonstrate a 
statistically significant association between CM and smoking abstinence during 
pregnancy. Previous studies have shown high rates (up to 40%) of smoking abstinence in 
late pregnancy for patients enrolled in CM. Our quit rate (45%) is similar.8 Our study also 
showed a trend in greater gestational age at birth, birth weights, APGAR scores, and 
fewer ICU visits in the CM group, which may be associated with the group’s greater rate 
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of smoking abstinence. These results were not statistically significant, which may be the 
result of the small size of our study. Some problems encountered with implementation of 
this program in our population include poor retention, low adherence, and a high 
prevalence of opiate drug use that may have skewed our data. Some solutions for these 
issues include adopting more accessible modalities for monitoring smoking abstinence 
(i.e. smart phone apps) to improve compliance and adherence as well as increasing the 
size of future studies to more effectively investigate the effects of CM on maternal 
cessation rates and birth outcomes. 
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